Earnings Expected To Decline, But Long-Term Investments May Provide Stability

AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Published
09 Feb 25
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
CN¥49.14
35.3% overvalued intrinsic discount
07 Aug
CN¥66.49
Loading
1Y
122.7%
7D
-0.4%

Author's Valuation

CN¥49.1

35.3% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on06 Aug 25
Fair value Increased 5.60%

Despite a weaker revenue outlook, a significantly improved net profit margin has led analysts to raise their consensus price target for New China Life Insurance from CN¥46.54 to CN¥49.14. What's in the News Board agreed to nominate Mr. ZHANG Xiaodong as a candidate for non-executive director for the eighth session.

Shared on01 May 25
Fair value Decreased 9.27%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 0.31%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.88%

AnalystConsensusTarget has increased revenue growth from -10.0% to -7.8% and decreased profit margin from 38.0% to 32.6%.

Shared on02 Apr 25
Fair value Increased 12%

AnalystConsensusTarget has increased revenue growth from -11.2% to -10.0%, decreased future PE multiple from 11.9x to 9.8x and increased shares outstanding growth rate from -0.0% to 0.0%.

Shared on26 Mar 25
Fair value Increased 8.01%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25